公司资料
Bio-Path Holdings 股价、新闻与催化剂
- 股票代码:
- BPTH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年9月21日
—
市值
股价为何变动
截至 2026年9月21日，BPTH 股价变化不大，收于 $0.0002。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Bio-Path Holdings is a biotechnology company focused on RNAi and nucleic-acid-based approaches to cancer. Its story has long centered on specialized oncology science and the challenge of turning it into a commercial asset.
所在地与行业分类
Bio-Path is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on clinical progress, preclinical validation, and capital discipline to keep its programs moving. Investors usually watch readouts, safety, and the ability to sustain runway.
生物医药行业定位
Bio-Path occupies a niche oncology platform position within biotech. It is highly sensitive to whether its nucleic-acid science can translate into differentiated cancer activity.
未来催化剂
- Bio-Path’s catalysts are liposomal oncology programs and any clinical update that keeps the platform credible. The stock remains highly sensitive to whether the next data point improves the development path.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。